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SERUM OSTEOPROTEGERIN LEVELS ARE INCREASED IN PATIENTS 
WITH CUSHING’S SYNDROME: A CASE-CONTROL STUDY
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Department of Clinical and Biological Sciences, Orbassano, University of Turin, Turin, Italy 
RANKL/RANK/OPG system plays a key-role in bone, immune and vascular systems. In vitro, glucocorti-
coids inhibit OPG and stimulate RANKL expression in different cell types. Few data are available on
serum OPG levels, and no data at all on serum sRANKL levels in Cushing’s syndrome (CS). We studied
38 patients with CS (male/female 17/21, age (median, range) 55, 23-80 years). Twenty-seven of them
had an ACTH-dependent syndrome (21 with Cushing’s disease (CD), 6 with ectopic ACTH hypersecre-
tion). Eleven had an adrenal–dependent syndrome (9 with adrenal adenoma (AA), 2 with adrenal carcino-
ma). 38 healthy subjects served as controls (male/female 16/22, age 55, 22-79 years). Serum concentra-
tions of OPG and total sRANKL were measured by ELISAs. Serum OPG levels were higher in CS pa-
tients than in controls (p<0.001); no significant difference was observed in serum sRANKL levels and
sRANKL/OPG ratio. Serum OPG levels positively correlated with age in controls (r=0.34, p<0.05) but not
in CS patients. Serum sRANKL levels and sRANKL/OPG ratio negatively correlated with age in controls
(r=-0.59, p<0.001, and r=-0.65, p<0.0001, respectively); these correlations were weaker in CS patients
(r=-0.30, p=0.09, and r=-0.33, p=0.05). In CS patients, OPG positively correlated with serum cortisol at
08:00 (r=0.43, p<0.01) and 24:00 (r=0.31, p=0.08), while sRANKL and sRANKL/OPG ratio negatively cor-
related with femur BMD, T- and Z-scores. Serum OPG levels were higher in CD than in AA patients. The
two groups were comparable for age and serum and 24-h urinary cortisol levels, but expectedly differed
for ACTH and DHEA-sulphate levels; consistently with previous results, lumbar and femur BMD values
were higher in CD than in AA patients (p<0.02). In conlusion, OPG but not sRANKL levels were increased
in CS patients: different tissues, including bone and endothelium, are likely to contribute to the observed
increase. In CS patients OPG levels positively correlated with serum cortisol, and were higher in CD than
in AA patients. Whether this difference is linked to the greater bone loss observed in AA with respect to
CD patients remains to be elucidated. In CS patients sRANKL levels and sRANKL/OPG ratio were in-
versely correlated with femur, but not spine, BMD parameters. Such a correlation is consistent with the bi-
ological role of RANKL as a major pro-resorptive factor.
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